Brugada syndrome classification: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
[[Image:Brugada 3.1.jpg| | [[Image:Brugada 3.1.jpg|left|thumb|400px|right|ECG pattern in Brugada syndrome. According to a recent consensus document, type 1 ST segment elevation either spontaneously present or induced with [[Ajmaline]]/[[Flecainide]] test is considered diagnostic. Type 1 and 2 may lead to suspicion but drug challenge is required for diagnosis. The ECGs in the right and left panels are from the same patient before (right panel, type 1) and after (left panel, type 1) endovenous administration of 1 mg/kg of Ajmaline during 10 minutes.]] | ||
==References== | ==References== | ||
Revision as of 13:38, 31 August 2012
|
Brugada syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Brugada syndrome classification On the Web |
|
American Roentgen Ray Society Images of Brugada syndrome classification |
|
Risk calculators and risk factors for Brugada syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Classification
- Type 1 ST segment elevation is diagnostic of Brugada syndrome and is characterized by a coved ST-segment elevation ≥2 mm (0.2 mV) followed by a negative T wave.
- Type 2 ST-segment elevation has a saddleback appearance with a high take-off ST-segment elevation of ≥2 mm followed by a trough displaying ≥1 mm ST elevation followed by either a positive or biphasic T wave.
- Type 3 ST-segment elevation has either a saddleback or coved appearance with an ST-segment elevation of <1 mm.
